Price T Rowe Associates Inc Elanco Animal Health Inc Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,035,506 shares of ELAN stock, worth $40.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,035,506
Previous 28,067,722
89.19%
Holding current value
$40.8 Million
Previous $405 Million
88.99%
% of portfolio
0.01%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1.12 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$707 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$658 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$313 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$286 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.37B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...